Capstone Therapeutics Corp (CAPS) financial statements (2020 and earlier)

Company profile

Business Address 1275 WEST WASHINGTON STREET
TEMPE, AZ 85281
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments111126
Cash and cash equivalents111126
Other current assets000010
Total current assets:111136
Noncurrent Assets
Property, plant and equipment     0
Long-term investments and receivables    66
Long-term investments    66
Intangible assets, net (including goodwill)000111
Intangible assets, net (excluding goodwill)000111
Other undisclosed noncurrent assets    (6)(6)
Total noncurrent assets:000111
TOTAL ASSETS:121237
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities000000
Accounts payable000000
Accrued liabilities000000
Total current liabilities:000000
Noncurrent Liabilities
Long-term debt and lease obligation2211  
Long-term debt, excluding current maturities2211  
Total noncurrent liabilities:2211  
Total liabilities:321100
Stockholders' equity
Stockholders' equity attributable to parent(1)(1)(0)137
Common stock000000
Additional paid in capital190190189189189189
Accumulated deficit(192)(191)(190)(189)(186)(182)
Total stockholders' equity:(1)(1)(0)137
TOTAL LIABILITIES AND EQUITY:121237

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:(2)     
Operating expenses(2)(2)(2)(3)(5)(4)
Other undisclosed operating income4     
Operating income (loss):0(2)(2)(3)(5)(4)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
0(0)(0)(0)  
Income (loss) from continuing operations before equity method investments, income taxes:0(2)(2)(3)(5)(4)
Other undisclosed income (loss) from continuing operations before income taxes    (0)0
Income (loss) from continuing operations before income taxes:0(2)(2)(3)(5)(4)
Income tax expense (benefit)(0)00000
Net income (loss):0(2)(2)(3)(4)(4)
Net income attributable to noncontrolling interest  1  0
Net income (loss) available to common stockholders, diluted:0(2)(1)(3)(4)(4)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):0(2)(2)(3)(4)(4)
Comprehensive income (loss):0(2)(2)(3)(4)(4)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest  1  (0)
Comprehensive income (loss), net of tax, attributable to parent:0(2)(1)(3)(4)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: